Literature DB >> 30387359

Insights into the Effects of Crack Abuse on the Human Metabolome Using a NMR Approach.

Tássia B B C Costa1, Acioly L T Lacerda2,3, Caroline Dal Mas3, Elisa Brietzke3, João G M Pontes1, Lucas A N Marins3, Lucas G Martins1, Marcel V Nunes2, Mariana Pedrini3, Michelle S C Carvalho3, Milan P Mitrovitch2, Mirian A F Hayashi3, Natália L Saldanha2, Ronei J Poppi1, Ljubica Tasic1.   

Abstract

Approximately 255 million people consume illicit drugs every year, among which 18 million use cocaine. A portion of this drug is represented by crack, but it is difficult to estimate the number of users since most are marginalized. However, there are no recognized efficacious pharmacotherapies for crack-cocaine dependence. Inflammation and infection in cocaine users may be due to behavior adopted in conjunction with drug-related changes in the brain. To understand the metabolic changes associated with the drug abuse disorder and identify biomarkers, we performed a 1H NMR-based metabonomic analysis of 44 crack users' and 44 healthy volunteers' blood serum. The LDA model achieved 98% of accuracy. From the water suppressed 1H NMR spectra analyses, it was observed that the relative concentration of lactate was higher in the crack group, while long chain fatty acid acylated carnitines were decreased, which was associated with their nutritional behavior. Analyses of the aromatic region of CPMG 1H NMR spectra demonstrated histidine and tyrosine levels increased in the blood serum of crack users. The reduction of carnitine and acylcarnitines and the accumulation of histidine in the serum of the crack users suggest that histamine biosynthesis is compromised. The tyrosine level points to altered dopamine concentration.

Entities:  

Keywords:  1H NMR; blood serum; cocaine; illicit drugs use; metabolomics; metabonomics

Mesh:

Substances:

Year:  2018        PMID: 30387359     DOI: 10.1021/acs.jproteome.8b00646

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

1.  Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans.

Authors:  Andrea E Steuer; Daria Kaelin; Martina I Boxler; Lisa Eisenbeiss; Friederike Holze; Patrick Vizeli; Joanna Czerwinska; Paul I Dargan; Vincenzo Abbate; Matthias E Liechti; Thomas Kraemer
Journal:  Metabolites       Date:  2020-07-27

2.  A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder.

Authors:  Md Altaf-Ul-Amin; Kazuhisa Hirose; João V Nani; Lucas C Porta; Ljubica Tasic; Shaikh Farhad Hossain; Ming Huang; Naoaki Ono; Mirian A F Hayashi; Shigehiko Kanaya
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

Review 3.  Forensic NMR metabolomics: one more arrow in the quiver.

Authors:  Emanuela Locci; Giovanni Bazzano; Alberto Chighine; Francesco Locco; Ernesto Ferraro; Roberto Demontis; Ernesto d'Aloja
Journal:  Metabolomics       Date:  2020-11-07       Impact factor: 4.290

4.  Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics.

Authors:  Melissa Quintero Escobar; Tássia Brena Barroso Carneiro Costa; Lucas G Martins; Silvia S Costa; André vanHelvoort Lengert; Érica Boldrini; Sandra Regina Morini da Silva; Luiz Fernando Lopes; Daniel Onofre Vidal; Ana C V Krepischi; Mariana Maschietto; Ljubica Tasic
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

Review 5.  Applications of Metabolomics in Forensic Toxicology and Forensic Medicine.

Authors:  Michal Szeremeta; Karolina Pietrowska; Anna Niemcunowicz-Janica; Adam Kretowski; Michal Ciborowski
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

6.  Dopamine D2 receptor signaling in the brain modulates circadian liver metabolomic profiles.

Authors:  Marlene Cervantes; Robert G Lewis; Maria Agnese Della-Fazia; Emiliana Borrelli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-10       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.